How to use the speech recognition tool?
NCT03359551
Night
Natural History of the Progression of Choroideremia Study NSR-CHM-OS1.
Type: Observational
Status of the trial: Completed
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2017-08-08
- Closing Date: 2018-12-29
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
- Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
- Reference Center Rare Diseases 'Genetic Sensory Diseases', MAOLYA, Montpellier, France
- Radboud university medical center, Nijmegen, Netherlands
- Moorfields Eye Hospital NHS Foundation Trust
- Central Manchester University Hospitals NHS Foundation Trust, Manchester AcademicHealth Sciences Centre (MAHSC)
- Nuffield Department of Clinical Neurosciences (NDCN) & Oxford Eye Hospital West Wing
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)